ArticleEye (London, England)2025

Comment on: 'Comparing safety and efficacy of Bevacizumab, Ranibizumab and Ranibizumab biosimilar in Retinopathy of prematurity'.

Isabelle RosetoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.